CERVICAL ADENOSQUAMOUS CARCINOMA
Clinical trials for CERVICAL ADENOSQUAMOUS CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CERVICAL ADENOSQUAMOUS CARCINOMA trials appear
Sign up with your email to follow new studies for CERVICAL ADENOSQUAMOUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shorter radiation may ease cervical cancer treatment in uganda
Disease control Recruiting nowThis study tests whether a shorter, higher-dose radiation schedule (hypofractionated) is as safe and effective as the standard longer schedule for women with locally advanced cervical cancer. About 278 women in Uganda will receive either the shorter or standard radiation, plus ch…
Matched conditions: CERVICAL ADENOSQUAMOUS CARCINOMA
Phase: PHASE2 • Sponsor: Uganda Cancer Institute • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
New drug targets tumors directly in early trial
Disease control Recruiting nowThis early-phase trial tests a new drug called AVA6103 in about 144 people with advanced solid tumors (like pancreatic, stomach, or lung cancer) that have not responded to standard treatments. The drug is designed to activate only inside tumors to kill cancer cells while limiting…
Matched conditions: CERVICAL ADENOSQUAMOUS CARCINOMA
Phase: PHASE1 • Sponsor: Avacta Life Sciences Ltd • Aim: Disease control
Last updated May 06, 2026 16:03 UTC